低降钙素原水平时遵循降钙素原抗生素处方指南推荐对 antibiotic 使用的影响
本研究为ProACT试验的回顾性分析,ProACT将14家美国医院1656例疑似下呼吸道感染患者随机分为常规护理组或向临床医生提供降钙素原检测结果及抗生素处方指南组。通过模拟不同依从率,发现医院内(急诊和住院)对低降钙素原指南推荐的依从率达84%时,可拒绝无效假设(3.7 vs 4.3抗生素使用天数,p=0.048);出院后持续依从的阈值为76%;仅急诊科100%依从仍未能减少抗生素天数。218例急诊科在低降钙素原下仍处方抗生素的患者中,153例(70.2%)为低或中风险。
要点
- 医院内(急诊和住院)对低降钙素原指南推荐的依从率需达84%才可能减少抗生素使用天数(3.7 vs 4.3天,p=0.048)。
- 出院后持续遵循指南的依从率阈值为76%。
- 仅急诊科内即使100%依从指南,也未能减少抗生素使用天数。
- 218例急诊科在低降钙素原下仍处方抗生素的患者中,153例(70.2%)为低或中风险。
- ProACT试验中观察到依从率为64.8%,未减少抗生素使用。
适用人群与场景
- 疑似下呼吸道感染、就诊于美国14家医院急诊科的患者(ProACT试验纳入人群)
诊断标准与关键阈值
- 低降钙素原水平(依据降钙素原抗生素处方指南推荐)
处置流程与药物剂量
- 向治疗临床医生提供降钙素原检测结果及抗生素处方指南。
- 医院内(急诊和住院)对低降钙素原指南推荐的依从率需达84%才可能减少抗生素使用天数。
- 出院后持续遵循指南的依从率阈值为76%。
- 对低降钙素原的低风险和中风险患者, withholding 抗生素可能提供抗生素减少的机会(作者结论)。
研究设计与关键结果
- 研究类型:ProACT试验的回顾性分析;ProACT随机1656例疑似下呼吸道感染患者至常规护理或提供降钙素原检测结果及抗生素处方指南。
- 主要结局:第30天抗生素使用天数,意向性治疗分析;医院内依从率84%时可拒绝无效假设(3.7 vs 4.3抗生素使用天数,p=0.048)。
- 出院后持续依从的阈值为76%;仅急诊科100%依从仍未能减少抗生素天数。
- 218例急诊科在低降钙素原下仍处方抗生素的患者中,153例(70.2%)为低或中风险。
证据类型、等级与局限
- 证据类型:对随机对照试验(ProACT)数据的回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 医院内对低降钙素原指南推荐的高依从(84%)是减少疑似下呼吸道感染抗生素使用的必要条件;出院后持续依从(阈值76%)及对低降钙素原低、中风险患者 withholding 抗生素可能提供有影响力的抗生素减少机会(作者结论)。
指南或共识出处
- 降钙素原抗生素共识试验(ProACT),ClinicalTrials.gov标识符:NCT02130986,首次发布2014年5月6日。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The Procalcitonin Antibiotic Consensus Trial (ProACT) found provision of a procalcitonin antibiotic prescribing guideline to hospital-based clinicians did not reduce antibiotic use. Possible reasons include clinician reluctance to follow the guideline, with an observed 64.8% adherence rate. In this study we sought to determine the threshold adherence rate for reduction in antibiotic use, and to explore opportunities to increase adherence.
METHODS: This study is a retrospective analysis of ProACT data. ProACT randomized 1656 patients presenting to 14 U.S. hospitals with suspected lower respiratory tract infection to usual care or provision of procalcitonin assay results and an antibiotic prescribing guideline to the treating clinicians. We simulated varying adherence to guideline recommendations for low procalcitonin levels and determined which threshold adherence rate could have resulted in rejection of the null hypothesis of no difference between groups at alpha = 0.05. We also performed sensitivity analyses within specific clinical settings and grouped patients initially prescribed antibiotics despite low procalcitonin into low, medium, and high risk of illness severity or bacterial infection.
RESULTS: Our primary outcome was number of antibiotic-days by day 30 using an intention-to-treat approach and a null hypothesis of no difference in antibiotic use. We determined that an 84% adherence rate in the hospital setting (emergency department and inpatient) for low procalcitonin could have allowed rejection of the null hypothesis (3.7 vs 4.3 antibiotic-days, p = 0.048). The threshold adherence rate was 76% for continued guideline adherence after discharge. Even 100% adherence in the emergency department alone failed to reduce antibiotic-days. Of the 218 patients prescribed antibiotics in the emergency department despite low procalcitonin, 153 (70.2%) were categorized as low or medium risk.
CONCLUSIONS: High adherence in the hospital setting to a procalcitonin antibiotic prescribing guideline is necessary to reduce antibiotic use in suspected lower respiratory tract infection. Continued guideline adherence after discharge and withholding of antibiotics in low and medium risk patients with low procalcitonin may offer impactful potential opportunities for antibiotic reduction. Trial registration Procalcitonin Antibiotic Consensus Trial (ProACT), ClinicalTrials.gov Identifier: NCT02130986. First posted May 6, 2014.
参考来源
- Malley BE, Yabes JG, Gimbel E, et al. Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use. BMC Infect Dis. 2023. PMID: 36658543. doi:10.1186/s12879-022-07923-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。